INNOVATOR SAMPLES – A GLOBAL SOURCING ENTERPRISE

YOUR ONE STOP SHOP FOR END TO END NEEDS OF INNOVATOR SAMPLES FOR CLINICAL TRIALS AND BIOEQUIVALENCE STUDIES

Every R&D project on Generic drugs/Biosimilars begins with an analysis of the Reference Listed Drug (RLD)/ Innovator Sample which is already in the market. The demand for such globally manufactured drugs is considerably large.

Generics/Biosimilars are showing high penetration in the pharma market across the globe. This is due to the factors, such as rising healthcare expenditure, ageing population, high incidences of diseases, as well as numerous blockbuster drugs going off patent in the US and European markets. The generic drug market is further anticipated to grow at a CAGR of 16.3%. (Source: RNCOS - Indian Generic Drug Market Outlook 2020)

We at Clinical Symbio, specialize in sourcing these Reference Listed Drugs (RLD)/Innovator Samples from across the globe, including Europe, USA, Canada, Australia, New Zealand, Japan, China and Rest of South East Asia. Our synergies with the top suppliers in the Global Markets have strengthened our capabilities to provide end-to-end services to clients all over the globe.

Our clients are typically Contract Research Organizations, Pharmaceutical Companies, Clinical Trial Sponsors, Clinical Trial Management Organizations or any such companies involved in investigational drug research.

Our decades of techno-commercial experience in the Pharma industry and our credibility amongst suppliers, customers and all other stake holders enables us to facilitate the most appropriate solutions based on clients requirements at best available costs.